Last reviewed · How we verify

NCT05430789

Post-discharge Cessation for Smoking Patients

Status unknown NA Last updated 19 July 2022
What this trial tests

NA trial testing 5As brief advice in Smoking Cessation in 770 participants. Status unknown.

Timeline
24 June 2022
Primary endpoint
31 May 2024
30 September 2024

Quick facts

Lead sponsorThe University of Hong Kong
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment770
Start date24 June 2022
Primary completion31 May 2024
Estimated completion30 September 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The University of Hong Kong

Who can join

18 and older, any sex, with Smoking Cessation or Post-discharge. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to enhance the general 5As brief advice model with interactive mobile phone-based intervention and active referral to community smoking cessation services for smoking patients discharged from hospitals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

Other The University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05430789.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing